Hi, and welcome to the board!
If you're new here, this has become a show-me stock, due to the trials of life on the OTC, CV radically changing our course, etc.
Next week's call is certainly a big chance for our CEO, Joe Moscato, to show us some of the fruits of the last year's efforts.
Not sure how much you know... but one of the most important items will be progress on the IPO of our 91% GNBT-owned (9% owned by us GNBT shareholders) separate company NGIO. Recent valuation placed NGIO above $500MM. Events since then may have caused that to increase.
If Joe has a successful IPO and good results/progress on the vaccine, he should be able to start to build businesses on top of all the good IP, scientific teams, etc.
I would guess we will see some info coming out as early as next Tue but definitely Wed or Th that will start to paint the picture for us a little better. So much potential and so much groundwork laid. We are truly getting close to seeing the "rubber hit the road"!
Should be a fun week!
If you're new here, this has become a show-me stock, due to the trials of life on the OTC, CV radically changing our course, etc.
Next week's call is certainly a big chance for our CEO, Joe Moscato, to show us some of the fruits of the last year's efforts.
Not sure how much you know... but one of the most important items will be progress on the IPO of our 91% GNBT-owned (9% owned by us GNBT shareholders) separate company NGIO. Recent valuation placed NGIO above $500MM. Events since then may have caused that to increase.
If Joe has a successful IPO and good results/progress on the vaccine, he should be able to start to build businesses on top of all the good IP, scientific teams, etc.
I would guess we will see some info coming out as early as next Tue but definitely Wed or Th that will start to paint the picture for us a little better. So much potential and so much groundwork laid. We are truly getting close to seeing the "rubber hit the road"!
Should be a fun week!
2
